Vivo Ventures Fund V, L.P., 10% Owner at Sagent Pharmaceuticals, Inc. (SGNT), sold 539,017 shares at $21.25 ($11.5M) on 2013-09-16, disclosed to the SEC on 2013-09-17.
Open-market sale of $11.5M SGNT by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.25 | 6,252 | $133K | 1.2% |
| 2 | $21.25 | 532,765 | $11.3M | 98.8% |
| Total | $21.25 avg | 539,017 | $11.5M | 100% |
| Filing → |
| SLNO | SELL | 2019-11-04 | $1.0M | — | Filing → |
| MEIP | SELL | 2013-10-03 | $343K | — | Filing → |